Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0IQ2P
|
|||
| Former ID |
DIB003800
|
|||
| Drug Name |
NexVax2
|
|||
| Synonyms |
Gluten epitope-based peptide vaccine (celiac disease), Nexpep
Click to Show/Hide
|
|||
| Indication | Coeliac disease [ICD-11: DA95; ICD-10: K90.0; ICD-9: 579] | Phase 1 | [1] | |
| Type-1 diabetes [ICD-11: 5A10; ICD-9: 250] | Phase 1 | [2] | ||
| Company |
Nexpep Pty Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT02528799) Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.